Peter Davey

Antimicrobial Chemotherapy

Ebook (PDF Format)

Antimicrobial agents are essential for the treatment of life-threatening infections and for managing the burden of minor infections in the community. In addition, they play a key role in organ and bone marrow transplantation, cancer chemotherapy, artificial joint and heart valve surgery. Unlike other classes of medicines, they are vulnerable to resistance from mutations in target microorganisms, and their adverse effects may extend to other patients (increased riskof cross-infection). As a consequence, there is a constant requirement for new agents, as well as practices that ensure the continued effective prescribing of licensed agents.The fu… Mehr

CHF 82.55

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen
Versandkostenfrei

Produktdetails

Weitere Autoren: Wilcox, Mark H. / Irving, William / Thwaites, Guy

ISBN: 978-0-19-100400-1
EAN: 9780191004001
Produktnummer: 18403388
Verlag: Oxford University Press
Sprache: Englisch
Erscheinungsjahr: 2015
Seitenangabe: 450 S.
Plattform: PDF
Masse: 14'920 KB
Auflage: 7. Auflage

Über den Autor

Peter Davey has over thirty years experience of research focused on the outcomes of antimicrobial chemotherapy and the relationships between prescribing and resistance. He trained as an Infectious Diseases Physician in Birmingham UK and at the Tufts New England Medical Centre in Boston. He was the first Director of the University of Dundee's Health Informatics Centre from 2003-6. He is past President of the International Society for Pharmacoeconomics and OutcomesResearch and of the British Society for Antimicrobial Chemotherapy. He is Surveillance and Stewardship Secretary of the British Society for Antimicrobial Chemotherapy.Mark Wilcox is a Consultant and Clinical Director of Microbiology and Pathology at Leeds Teaching Hospitals NHS Trust. His is also Professor of Medical Microbiology, University of Leeds, UKWill Irving qualified in Medicine from Cambridge, and completed a PhD in Immunology, before specializing in Virology .Will's main interest is in viral hepatitis. He chairs the Department of Health Advisory Group on Hepatitis, and is co-chair of HCV Research UK (a national cohort of patients with hepatitis C virus infection). Will is also a keen bridge player, and avid Leeds Rhinos and Utd fan.Guy Thomas qualified from Cambridge University and the United Medical and Dental schools of Guy's and St Thomas' and trained in Infectious Diseases and Microbiology in Brighton, the Oxford University Clinical Research Unit (OUCRU) in Vietnam, Imperial College London, and the Hospital for Tropical Diseases in London. Guy held Wellcome Trust Training and Intermediate Fellowships to study tuberculosis; and is a founder and Chairman of the UK Clinical Infection Research Group. Between 2011 and 2013he was a Reader in Infectious Diseases at King's College London and Honorary Consultant in Infectious Diseases and Clinical Microbiology at Guy's and St. Thomas' NHS Foundation trust, before returning to Vietnam in 2013 to take over as Director of OUCRU.